SCHOEDEL, PHD, K. A.; ROLLERI, PHARMD, R. L.; FAULKNOR, MD, CCFP, J. Y.; PIXTON, MS, G. C.; CHEN, PHD, N.; BASS, PHARMD, A.; SOMMERVILLE, MD, K. W.; SELLERS, MD, PHD, FRCPC, FACP, E. Assessing subjective and physiologic effects following intranasal administration of a new formulation of immediate release oxycodone HCl (Oxecta™) tablets in nondependent recreational opioid users. Journal of Opioid Management, [S. l.], v. 8, n. 5, p. 315–327, 2012. DOI: 10.5055/jom.2012.0131. Disponível em: https://wmpllc.org/ojs/index.php/jom/article/view/693. Acesso em: 28 apr. 2024.